Primary effusion lymphoma-like lymphoma (PEL-LL) is a rare B-cell lymphoma that the etiology remains unclear. We describe a case of PEL-LL with a pleuropericardial effusion. Diagnosis required long period of time as it followed a unique progress of disappearance and recurrence of the body cavity effusion. We finally had a diagnosis of B-cell lymphoma by the immunocytochemistry of effusion using the cell block procedure. Authors consider that it is valuable to actively try the cell block procedure at the time of the first drainage for early diagnosis, if the body cavity effusion due to the malignancy is suspected. 
B-cell lymphoma by the immunocytochemistry of effusion using the cell block procedure. Authors consider that it is valuable to actively try the cell block procedure at the time of the first drainage for early diagnosis, if the body cavity effusion due to the malignancy is suspected.
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| INTRODUCTION
Primary effusion lymphoma (PEL) is one of the diffuse large B-cell lymphomas (DLBCL) which is characterized by lymphomatous effusion in body cavities without detectable tumor masses. 1 PEL is known as a rare disease that accounts for approximately 4% of all human immunodeficiency virus (HIV)-associated non-Hodgkin's lymphoma. 2 All PEL cases have human herpes virus 8 (HHV-8) infection, and the 90% of the all cases also contain Epstein-Barr virus (EBV). 3 Recently, some reports described PEL-like disease process in HHV-8 as negative cases.
These diseases are referred to PEL-like lymphoma (PEL-LL). 4 
| CASE PRESENTATION
A 75-year-old male was admitted to a local hospital for dyspnea and chest oppression with jugular venous distention. The blood pressure at the time of the admission was 119/92 mm Hg, and heart rate was 120 beats per minute. Chest computerized tomography (CT) scan showed a large pericardial and bilateral pleural effusion (Figure 1 ), and laboratory data were as follows (Table 1) : the elevation of liver enzymes, mild renal dysfunction. There was no sign of hypoalbuminemia and cirrhosis. The antinuclear antibody, rheumatoid factor, thyroid-stimulating hormone, free T3, and free T4 were normal distribution. There was no finding of special note such ST elevation on electrocardiograph. Echocardiography revealed interventricular septum wall motion abnormality and pericardial effusion.
We diagnosed the patient's condition as a circulatory insufficiency due to pericardial effusion, and he underwent drainage of pericardial and left pleural effusion, and the former did not appear again. 
| DISCUSSION
To date, few papers have investigated the clinical features and the treatment of PEL-LL patients who are generally elderly, express CD20
for pan-B-cell antigens, and have a slow prognosis for mortality. 5, 6 PEL has a strong prognosis for mortality during the early phase, whereas the literature includes numerous reports of favorable responses to F I G U R E 1 CT scan of chest with pleuropericardial effusion we performed R-CHOP therapy. 10 There was no recurrence of the body cavity effusion after chemotherapy, and it seemed that a constant effect was provided.
This case was suffered from a diagnosis of malignant lymphoma as the sIL-2R value was within the standard value, and it followed a unique progress of disappearance and recurrence of the body cavity effusion. The causes of the pericardial effusion as for the ratio that a malignant lymphoma accounted for were 6%, and an unidentified accounted for 9%. 11 In addition, several reports have demonstrated that the sIL-2R value was low in patients with PEL-LL. 12, 13 It may be necessary to consider possibility of latent PEL-LL regardless of the sIL-2R value.
Terasaki et al. 7 have reported disappearance of malignant cells by first drainage with PEL-LL, and it seems that performing secondary drainage becomes difficult. Thus, the cell block procedure which can make multiple specimens at the time of the first drainage in anticipation of the immunocytochemistry may be the best technique for examination of body cavity effusions when the case of relationship of malignant lymphoma cannot be denied. PEL-LL is a rare disease; it seemed that the primary care physician is the first one to contact the patient with the body cavity effusion, and it was considered as one of the differential diagnoses at the first contact. 
